Benign prostatic hyperplasia (BPH) is an age-related, nonmalignant condition that may lead to bothersome lower urinary tract symptoms. The standard treatment of BPH has been ordinary loop transurethral prostatectomy, but new therapies have been developed as a combined result of research, technological...
Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients 2024, Diagnostic and Interventional Imaging Citation Excerpt : The first-line treatment is still pharmacological and the range of available medications has...
A placebo-controlled study with progesterone compound, 17-alphahydroxyprogesterone 17-n-caproate (Primostat), in 39 patients with benign enlargement of the prostate is reported. Statistical analysis of the results showed no evidence of significant improvement in patients receiving hydroxyprogesterone-caproate...
An apparatus and a method for treatment of benign prostatic hyperplasia are disclosed. The apparatus includes an applica torpiece carrying a set of electrodes shaped and positioned to create a substantial electric field in the volume of hyperplasia and a pulse generator adapted for delivery of electr...
However, with the emergence of medical therapies as first-line treatment and the expansion of medical therapy for lower urinary tract symptoms (LUTS) into... MM Miner - 《Current Urology Reports》 被引量: 64发表: 2009年 Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower...
The report summarizes a pilot study originally designed to address the questionof increased mortality following transurethral resection of the prostate (TURP) and the relative effectiveness of different treatment strategies for benign prostatic hyperplasia (BPH). A total of 175 patients at four clinical ...
Physicians at UC San Diego Health are now offering prostate artery embolization (PAE) as a new treatment option for men with benign prostatic hyperplasia (BPH), or an enlarged prostate. The minimally invasive procedure is an alternative to surgery, with
摘要: 'UroLift' has emerged as a new minimally-invasive nonablative surgical technique for benign prostatic hyperplasia (BPH). We discuss the procedure, cost, evidenc关键词: BPH, prostate, PUL, UroLift DOI: 10.1177/1756287216671497 年份: 2016 ...
The armamentarium of minimally invasive treatment modalities for patients with benign prostatic hyperplasia has constantly increased during the past decade. The energy sources used range from micro-/radiofrequency waves to high-intensity focused ultrasound, laser vaporization/coagulation/resection and electrosur...
Context: Clinical trials of phosphodiesterase type 5 inhibitors (PDE5-Is) have consistently demonstrated a significant reduction in lower urinary tract symptoms (LUTS) and small urinary flow rate changes in men with benign prostatic hyperplasia (BPH). Objective: This review presents the proposed mechan...